{
    "Trade/Device Name(s)": [
        "LabonaCheck Gluppy Blood Glucose Monitoring System",
        "LabonaCheck Gluppy Control Solution",
        "LabonaCheck Gluppy Blood Glucose Test Strips"
    ],
    "Submitter Information": "CERAGEM Medisys Inc.",
    "510(k) Number": "K102751",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081451"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "February 11, 2013",
    "Summary Letter Received Date": "February 7, 2013",
    "Submission Date": "January 28, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LabonaCheck Gluppy Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Enzyme reaction (Glucose Oxidase)",
        "Mediator (Potassium ferricyanide)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Control Solution",
        "Test Strips",
        "Meter",
        "Lancing Device",
        "Lancets",
        "Accessory",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for LabonaCheck Gluppy Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood using amperometry.",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home to quantitatively measure glucose in fresh capillary whole blood from the fingertip; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}